Medicine and Dentistry
Prostate Cancer
100%
Positron Emission Tomography-Computed Tomography
83%
Magnetic Resonance Imaging
72%
Fluorine-18
50%
Radioisotope
50%
Contrast-Enhanced Ultrasound
50%
Recurrent Disease
40%
Lymph Node Metastasis
39%
Neoplasm
37%
Biochemical Recurrence
36%
Brain Ischemia
36%
Gallium 68
35%
Stenosis
23%
Meta-Analysis
21%
Cancer Diagnostics
19%
Carotid Artery
19%
Apoplexy
18%
Cancer Staging
18%
Translational Research
18%
Venous Ulcer
18%
Carotid Atherosclerosis
17%
Calciphylaxis
17%
Thyroid Nodule
16%
Chronic Liver Disease
16%
Ultrasonography
16%
Tumor Differentiation
16%
Vascularity
16%
Kidney Tumour
16%
Clear Cell Renal Cell Carcinoma
16%
Molecular Imaging
16%
Steatosis
16%
Methanol Poisoning
16%
Deterioration
16%
Prognostic Factor for Prostate Cancer
16%
Microvascularization
16%
Acoustic Shadow
16%
Computed Tomography Angiography
16%
Recurrence Risk
14%
Bone Metastasis
13%
Prostatectomy
11%
Vasa Vasorum
11%
Bone Scintigraphy
10%
Fibrosis
10%
Gleason Score
10%
Radiopharmaceutical
9%
Non Invasive Procedure
8%
Basal Ganglia
8%
Lymph Node
6%
Acute Myelogenous Leukemia
6%
Adenoma
6%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
83%
Polyethylene Terephthalate
83%
Fluorine 18
50%
Recurrent Disease
48%
Lymph Node Metastasis
38%
Biochemical Recurrence
36%
Gallium 68
36%
Neoplasm
33%
Neovascularization (Pathology)
16%
Chronic Liver Disease
16%
Renal Cell Carcinoma
16%
Radioisotope
16%
Steatosis
16%
Methanol Poisoning
16%
Deterioration
16%
Recurrence Risk
14%
Fibrosis
10%
Cerebrovascular Accident
8%
Brain Ischemia
8%
Stenosis
8%
Bone Metastasis
7%
Gleason Score
6%
